Position in CGON
as of Mar 31, 2026
· filed Apr 28, 2026
Position Value
$227,201
New position
Shares Held
3,357
first reported quarter
Ownership
0.004%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Abel Hall, LLC holds $15,603,659 across 68 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
5,394 | $1,010,188 | |
| 2 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
1,389 | $745,823 | |
| 3 | TGTX |
Tg Therapeutics, Inc.
|
13,570 | $745,535 | |
| 4 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
8,329 | $678,896 | |
| 5 | KYMR |
Kymera Therapeutics, Inc.
|
4,681 | $536,770 | |
| 6 | PTGX |
Protagonist Therapeutics, Inc
|
4,286 | $525,377 | |
| 7 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,050 | $521,566 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
6,619 | $492,983 |
All Filings in CGON
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $227,201 | 3,357 | Shares | Sole | 2026-04-28 | |
| No filing history on record for this holder in this stock. | ||||||